<?xml version="1.0" encoding="UTF-8"?>
<p>In the latter RCT the supplemental therapy with 
 <italic>Antrodia cinnamomea</italic> for chemotherapy in advanced adenocarcinomas showed no significant difference in OS compared to placebo (
 <xref rid="B52" ref-type="bibr">Tsai et al., 2016</xref>). Progression of the disease was the leading cause of death in four (33.3%) verum and eight (66.7%) placebo recipients. Mean OS was 5.4 months in the verum group and 5 months in the placebo group (
 <italic>p</italic> = 0.340), and disease control rates were 41.2% and 55% respectively (
 <italic>p</italic> = 0.33).
</p>
